Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia

Published:2020-08-17 Issue:2 Volume:109 Page:425-436
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:J Leukoc Biol

Author:

Wan Zhuoya¹,Sun Runzi²,Moharil Pearl³⁴,Chen Jing¹⁴,Liu Yuzhe⁵,Song Xu¹,Ao Qiang¹^ORCID

Affiliation:

1. Institute of Regulatory Science for Medical Device, National Engineering Research Center for Biomaterials Sichuan University Chengdu China

2. Department of Immunology, School of Medicine University of Pittsburgh Pennsylvania USA

3. Department of Cell Biology, Harvard Medical School Harvard University Massachusetts USA

4. Department of Pharmaceutical Science, School of Pharmacy University of Pittsburgh Pennsylvania USA

5. Department of Materials Engineering Purdue University Indiana USA

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/JLB.5MR0620-063RR

Reference112 articles.

1. Advances in adult acute lymphoblastic leukemia therapy

2. Chronic myeloid leukaemia

3. ‘Acute myeloid leukemia: a comprehensive review and 2016 update’

4. Chronic lymphocytic leukaemia

5. Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced nanotherapeutics inspired by the abnormal microenvironment of leukemia;Nano Research;2024-07-17

2. Nanozymes: a new approach for leukemia therapy;Journal of Materials Chemistry B;2024

3. Advances in Nanotechnology for Enhanced Leukemia Therapy: A Systematic Review of In Vivo Studies;Journal of Lab Animal Research;2023-12-25

4. Advantages of nanomedicine over the conventional treatment in Acute myeloid leukemia;Journal of Biomaterials Science, Polymer Edition;2023-12-19

5. Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment;Pharmaceutics;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3